Immuron (IMRN) Research & Development (2016 - 2025)

Immuron has reported Research & Development for 10 years, with the latest figure at -$2.3 million in Q2 2025.

• On a quarterly basis, Research & Development rose 34.97% year-over-year to -$2.3 million in Q2 2025; TTM through Jun 2025 was -$7.6 million, a 112.61% decrease from a year earlier, with the FY2026 full-year figure at -$1.9 million, down 5274.7% from the prior year.
• Research & Development was -$2.3 million for Q2 2025 at Immuron, down from -$35818.6 in the prior quarter.
• The five-year high for Research & Development was $1.5 million in Q4 2022, with the low at -$3.5 million in Q2 2024.
• Average Research & Development over 5 years is -$836295.7, with a median of -$544262.8 recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Research & Development soared 480.18% in 2022, then slumped 2491.9% in 2024.
• Over 5 years, Research & Development stood at $262268.2 in 2021, then jumped by 480.18% to $1.5 million in 2022, then sank by 210.9% to -$1.7 million in 2023, then jumped by 97.88% to -$35818.6 in 2024, then plunged by 6331.94% to -$2.3 million in 2025.
• The last three Research & Development figures came in at -$2.3 million (Q2 2025), -$35818.6 (Q3 2024), and -$3.5 million (Q2 2024), per Business Quant data.